Literature DB >> 25313320

Novel Type of Prodrug Activation through a Long-Range O,N-Acyl Transfer: A Case of Water-Soluble CREB Inhibitor.

Bingbing X Li1, Fuchun Xie1, Qiuhua Fan1, Kerry M Barnhart2, Curtis E Moore3, Arnold L Rheingold3, Xiangshu Xiao4.   

Abstract

CREB (cAMP response element binding protein) has been shown to play an important role in tumor initiation, progression, and metastasis. We discovered that naphthol AS-E, a cell-permeable CREB inhibitor, presented antiproliferative activity in a broad panel of cancer cell lines in vitro. However, it has limited aqueous solubility. In this report, we described a water-soluble inhibitor (compound 6) of CREB-mediated gene transcription with in vivo anticancer activity. Unexpectedly, compound 6 was found to be a prodrug of compound 12 necessitating an unprecedented long-range O,N-acyl transfer. The rate of this transfer was pH- and temperature-dependent. To the best of our knowledge, this is the first time to show that a long-range O,N-acyl transfer could be exploited as a prodrug activation strategy to improve aqueous solubility. This type of prodrug may be applicable to other structures with spatially arranged hydroxyl amide to improve their aqueous solubility.

Entities:  

Keywords:  CREB; O,N-acyl transfer; anticancer; prodrug; water-soluble inhibitor

Year:  2014        PMID: 25313320      PMCID: PMC4190631          DOI: 10.1021/ml500330n

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  27 in total

Review 1.  CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals.

Authors:  A J Shaywitz; M E Greenberg
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

2.  A novel approach of water-soluble paclitaxel prodrug with no auxiliary and no byproduct: design and synthesis of isotaxel.

Authors:  Yoshio Hayashi; Mariusz Skwarczynski; Yoshio Hamada; Youhei Sohma; Tooru Kimura; Yoshiaki Kiso
Journal:  J Med Chem       Date:  2003-08-28       Impact factor: 7.446

3.  Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions.

Authors:  I Radhakrishnan; G C Pérez-Alvarado; D Parker; H J Dyson; M R Montminy; P E Wright
Journal:  Cell       Date:  1997-12-12       Impact factor: 41.582

4.  Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133.

Authors:  G A Gonzalez; M R Montminy
Journal:  Cell       Date:  1989-11-17       Impact factor: 41.582

5.  Recruitment of CREB binding protein is sufficient for CREB-mediated gene activation.

Authors:  J R Cardinaux; J C Notis; Q Zhang; N Vo; J C Craig; D M Fass; R G Brennan; R H Goodman
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

6.  CREB is a novel nuclear target of PTEN phosphatase.

Authors:  Tingting Gu; Zhong Zhang; Jianli Wang; Junyi Guo; Wen Hong Shen; Yuxin Yin
Journal:  Cancer Res       Date:  2011-03-08       Impact factor: 12.701

7.  cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis.

Authors:  D Wu; H E Zhau; W-C Huang; S Iqbal; F K Habib; O Sartor; L Cvitanovic; F F Marshall; Z Xu; L W K Chung
Journal:  Oncogene       Date:  2007-02-19       Impact factor: 9.867

8.  Synthesis and evaluation of myxochelin analogues as antimetastatic agents.

Authors:  Satoshi Miyanaga; Hiroaki Sakurai; Ikuo Saiki; Hiroyasu Onaka; Yasuhiro Igarashi
Journal:  Bioorg Med Chem       Date:  2009-02-25       Impact factor: 3.641

9.  Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation.

Authors:  B E Wadzinski; W H Wheat; S Jaspers; L F Peruski; R L Lickteig; G L Johnson; D J Klemm
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

10.  Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis.

Authors:  Alok Chhabra; Herman Fernando; Gareth Watkins; Robert E Mansel; Wen G Jiang
Journal:  Oncol Rep       Date:  2007-10       Impact factor: 3.906

View more
  7 in total

1.  Design, synthesis and biological evaluation of regioisomers of 666-15 as inhibitors of CREB-mediated gene transcription.

Authors:  Fuchun Xie; Bingbing X Li; Xiangshu Xiao
Journal:  Bioorg Med Chem Lett       Date:  2016-12-31       Impact factor: 2.823

2.  Design, synthesis and evaluation of antitumor acylated monoaminopyrroloquinazolines.

Authors:  Bo Chao; Bingbing X Li; Xiangshu Xiao
Journal:  Bioorg Med Chem Lett       Date:  2017-05-16       Impact factor: 2.823

3.  Mechanistic insights into the activation of ester prodrugs of 666-15.

Authors:  Fuchun Xie; Pedro Martín-Acosta; Bingbing X Li; Xiangshu Xiao
Journal:  Bioorg Med Chem Lett       Date:  2020-07-28       Impact factor: 2.823

4.  Identification of a Potent Inhibitor of CREB-Mediated Gene Transcription with Efficacious in Vivo Anticancer Activity.

Authors:  Fuchun Xie; Bingbing X Li; Alina Kassenbrock; Changhui Xue; Xiaoyan Wang; David Z Qian; Rosalie C Sears; Xiangshu Xiao
Journal:  J Med Chem       Date:  2015-06-05       Impact factor: 7.446

Review 5.  What turns CREB on? And off? And why does it matter?

Authors:  André Steven; Michael Friedrich; Paul Jank; Nadine Heimer; Jan Budczies; Carsten Denkert; Barbara Seliger
Journal:  Cell Mol Life Sci       Date:  2020-04-28       Impact factor: 9.261

6.  A suite of bioassays to evaluate CREB inhibitors.

Authors:  Bingbing X Li; Xiangshu Xiao
Journal:  Methods Enzymol       Date:  2019-11-22       Impact factor: 1.682

7.  Systemic Inhibition of CREB is Well-tolerated in vivo.

Authors:  Bingbing X Li; Ryan Gardner; Changhui Xue; David Z Qian; Fuchun Xie; George Thomas; Steven C Kazmierczak; Beth A Habecker; Xiangshu Xiao
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.